Provided by Tiger Fintech (Singapore) Pte. Ltd.

IDEAYA Biosciences

24.75
+0.42001.73%
Volume:1.09M
Turnover:27.06M
Market Cap:2.17B
PE:-6.54
High:25.11
Open:24.35
Low:24.18
Close:24.33
52wk High:40.74
52wk Low:13.45
Shares:87.64M
Float Shares:82.44M
Volume Ratio:1.26
T/O Rate:1.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7869
EPS(LYR):-3.3605
ROE:-35.09%
ROA:-23.84%
PB:2.26
PE(LYR):-7.37

Loading ...

IDEAYA Biosciences Announces Board Restructuring Plans

TIPRANKS
·
Apr 03

IDEAYA Biosciences Announces Participation in Upcoming April 2025 Investor Relations Events

PR Newswire
·
Apr 01

IDEAYA Biosciences: Buy Rating Affirmed Amid FDA Breakthrough and Promising Clinical Developments

TIPRANKS
·
Apr 01

BUZZ-U.S. STOCKS ON THE MOVE-Veritex, Gaming and Leisure Properties, Apple

Reuters
·
Apr 01

BUZZ-Ideaya falls as analysts cautious despite eye cancer drug receiving FDA's 'breakthrough' tag

Reuters
·
Apr 01

IDEAYA's Eye Cancer Therapy Receives Breakthrough Therapy Designation From FDA

MT Newswires Live
·
Mar 31

BRIEF-IDEAYA Biosciences Receives US FDA Breakthrough Therapy Designation For Darovasertib Monotherapy In Neoadjuvant Uveal Melanoma

Reuters
·
Mar 31

BRIEF-IDEAYA Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
Mar 28

BRIEF-IDEAYA Announces Oral Presentation at the New Drugs on the Horizon Series at AACR 2025 for IDE275 (GSK959), a Phase 1 Werner Helicase Inhibitor

Reuters
·
Mar 26

IDEAYA Biosciences, Inc. (IDYA) Partners with ATTMOS for AI-Driven Drug Discovery Platform

Insider Monkey
·
Mar 06

IDEAYA Biosciences, ATTMOS Collaborate to Advance Small Molecule Discovery for Undruggable Oncology Targets

MT Newswires Live
·
Mar 04

Ideaya Biosciences announces research collaboration with Attmos

TIPRANKS
·
Mar 03

IDEAYA Biosciences Announces Collaboration with ATTMOS to Accelerate AI/ML-Enabled Drug Discovery for Unprecedented First-in-Class Oncology Targets

PR Newswire
·
Mar 03

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

PR Newswire
·
Feb 28

Cautious Hold Rating on IDEAYA Biosciences Amid Anticipated Equity Raises and Financial Pressures

TIPRANKS
·
Feb 23

IDEAYA Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Feb 18

U.S. RESEARCH ROUNDUP-Boeing, Philip Morris, Walmart

Reuters
·
Feb 17

IDEAYA Biosciences Reports 2024 Financials and Business Update

TIPRANKS
·
Feb 15

Wedbush Keeps Their Buy Rating on IDEAYA Biosciences (IDYA)

TIPRANKS
·
Feb 14

RBC Lowers Price Target on IDEAYA Biosciences to $57 From $61, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Feb 14